NeuroOne

NeuroOne's mission is to advance neurology through superior thin-film electrode technology, offering improved biocompatibility and signal fidelity over traditional devices. The company has achieved commercial validation with multiple FDA 510(k) clearances for its diagnostic (Evo® sEEG/Cortical) and therapeutic (OneRF® Ablation) systems. Its strategy is to first establish its electrodes as a standard in diagnostic monitoring and then leverage the same platform for therapeutic ablation, creating an integrated solution. This positions NeuroOne to capture value across the epilepsy and neuromodulation markets.

Proprietary flexible thin-film electrode technology for high-definition neural recording and integrated therapeutic ablation, enabling a diagnostic-to-therapeutic continuum in a single platform.

Competes against large device companies (Medtronic, Integra) offering traditional electrodes and separate ablation/laser systems. NeuroOne's key differentiator is its FDA-cleared, integrated platform using the same electrode for diagnosis and therapy, a unique offering in the market.